JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

Начало・Списък с акции・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Затворен

СекторЗдравеопазване

23.96 11.03

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

21.58

Максимум

25.97

Ключови измерители
By Trading Economics
Приходи	-8.4M -30M
Продажби	-6.9M 76M
Марж на печалбата	-39.073
Служители	888
EBITDA	-2.9M -22M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+52.93% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-158M 1.4B
Предишно отваряне	12.93
Предишно затваряне	23.96

Настроения в новините

By Acuity

50%

201 / 348 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

52.655 / 56.31 Подкрепа & съпротива

PROCEPT BioRobotics Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

29.04.2026 г., 23:53 ч. UTC

Печалби

Naver Posts Weaker First-Quarter Earnings

29.04.2026 г., 23:41 ч. UTC

Горещи акции

Stocks to Watch: Meta Platforms, Alphabet, Qualcomm, Amazon.com

29.04.2026 г., 23:55 ч. UTC

Печалби

Samsung Electronics 1Q Net Profit Beat FactSet-Compiled Consensus

29.04.2026 г., 23:54 ч. UTC

Печалби

Samsung Electronics 1Q Net KRW47.225T Vs. Net KRW8.223T >005930.SE

29.04.2026 г., 23:52 ч. UTC

Печалби

Samsung Electronics 1Q Oper Pft KRW57.233T Vs. Pft KRW6.685T >005930.SE

29.04.2026 г., 23:51 ч. UTC

Печалби

Samsung Electronics 1Q Rev KRW133.873T Vs. KRW79.141T >005930.SE

29.04.2026 г., 23:51 ч. UTC

Пазарно говорене

Nikkei May Fall Amid Uncertainty Over Mideast Conflict -- Market Talk

29.04.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Technical Recovery -- Market Talk

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Results Supported By Higher Income From Fees, Commission>6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial Gains From Changes in Fair Value on Financial Assets Also Aided Results>6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Net CNY3.67B Vs. Net CNY1.84B >6066.HK

29.04.2026 г., 23:24 ч. UTC

Печалби

CSC Financial 1Q Rev CNY7.70B Vs. CNY4.74B >6066.HK

29.04.2026 г., 23:22 ч. UTC

Печалби

China Longyuan 1Q Net CNY1.70B, Down 14%

29.04.2026 г., 23:22 ч. UTC

Печалби

China Longyuan: Power Generation Down 2.9% as of End-March

29.04.2026 г., 23:20 ч. UTC

Печалби

China Longyuan: 1Q Rev From Wind Power Fell, Rev From Solar Power Rose

29.04.2026 г., 23:20 ч. UTC

Печалби

China Longyuan 1Q Rev CNY7.87B, Down 3.6%

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Loss CNY5.95B Vs. Loss CNY6.25B >000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke: Weak China Real Estate Market Continue to Weigh on Results>000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Rev CNY28.93B Vs. CNY37.99B >000002.SZ

29.04.2026 г., 23:19 ч. UTC

Печалби

China Vanke 1Q Loss Narrows>000002.SZ

29.04.2026 г., 23:18 ч. UTC

Печалби

Naver1Q Net Profit Missed FactSet-Compiled Consensus

29.04.2026 г., 23:17 ч. UTC

Печалби

Naver 1Q Net KRW291.00B Vs. Net KRW423.70B >035420.SE

29.04.2026 г., 23:15 ч. UTC

Печалби

Naver 1Q Oper Pft KRW541.80B Vs. Pft KRW505.30B >035420.SE

29.04.2026 г., 23:15 ч. UTC

Печалби

Naver 1Q Rev KRW3.241T Vs. KRW2.787T >035420.SE

29.04.2026 г., 23:13 ч. UTC

Печалби

CICC: Gains From Investments in Financial Instruments Also Aided Results >3908.HK

29.04.2026 г., 23:12 ч. UTC

Печалби

CICC Results Supported by Increase in Fee, Commission Income >3908.HK

29.04.2026 г., 23:11 ч. UTC

Печалби

CICC 1Q Rev CNY8.83B Vs. CNY5.72B >3908.HK

29.04.2026 г., 23:11 ч. UTC

Печалби

CICC 1Q Net CNY3.58B Vs. Net CNY2.04B >3908.HK

29.04.2026 г., 23:04 ч. UTC

Печалби

Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist -- WSJ

29.04.2026 г., 23:04 ч. UTC

Печалби

Meta Reports Big Revenue Jump and Projected Spending Increase -- 3rd Update

Сравнение с други в отрасъла

Ценова промяна

PROCEPT BioRobotics Corp Прогноза

Ценова цел

By TipRanks

52.93% нагоре

12-месечна прогноза

Среден 35.22 USD 52.93%

Висок 60 USD

Нисък 20 USD

Според 11 анализатори от Wall Street, предложили 12-месечна ценова цел за PROCEPT BioRobotics Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

11 ratings

Купи

Задържане

Продай

Според 11 анализатори, дали борсови рейтинги на PROCEPT BioRobotics Corp през последните 3 месеца.

Техническа оценка

By Trading Central

52.655 / 56.31Подкрепа & съпротива

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Настроение

By Acuity

201 / 348 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.